2.4.1.65	0.005	-	GDP-L-fucose	reaction with Galbeta(1,4)GlcNAc	637635	
2.4.1.65	0.00573	-	GDP-beta-L-fucose	37°C, pH 6.5	680029	
2.4.1.65	0.0105	-	GDP-L-fucose	reaction with Galbeta(1,3)GlcNAc	637635	
2.4.1.65	0.0119	-	GDP-beta-L-fucose	cosubstrate: Galbeta1,3GlcNAc-O(CH2)8CO2CH3, truncated enzyme UA948(1-428)	680736	
2.4.1.65	0.012	-	Galbeta(1,4)(5-thioGlc)	-	637634	
2.4.1.65	0.013	-	GDP-L-fucose	FUT10-391	704613	
2.4.1.65	0.0131	-	GDP-L-fucose	reaction with lactose	637635	
2.4.1.65	0.015	-	GDP-L-fucose	FUT10-479	704613	
2.4.1.65	0.016	-	Galbeta(1,4)GlcNAcbetaOallyl	-	637634	
2.4.1.65	0.016	-	GDP	-	637635	
2.4.1.65	0.03	-	GDP-fucose	mutant W124R, with Fuc-alpha-1,2Gal-beta-1,4GlcNAc-sp-biotin	661839	
2.4.1.65	0.03	-	GDP-L-fucose	mutant enzyme W111R	637646	
2.4.1.65	0.032	-	GDP-L-fucose	mutant enzyme W111R/D112E	637646	
2.4.1.65	0.033	-	GDP-L-fucose	mutant enzyme D112E	637646	
2.4.1.65	0.0336	-	GDP-L-fucose	fucosyltransferase III	637645	
2.4.1.65	0.0337	-	GDP-beta-L-fucose	cosubstrate: Galbeta1,3GlcNAc-O(CH2)8CO2CH3, full-length enzyme	680736	
2.4.1.65	0.034	-	Galbeta(1,4)Glucal	-	637634	
2.4.1.65	0.034	-	GDP-fucose	mutant W111Y, with Fuc-alpha-1,2Gal-beta-1,3GlcNAc-sp-biotin	661839	
2.4.1.65	0.035	-	Galbeta(1,4)GlcNAc	-	637634	
2.4.1.65	0.035	-	GDP-fucose	mutant W124Y, with Fuc-alpha-1,2Gal-beta-1,4GlcNAc-sp-biotin	661839	
2.4.1.65	0.035	-	GDP-fucose	wildtype, with Fuc-alpha-1,2Gal-beta-1,3GlcNAc-sp-biotin	661839	
2.4.1.65	0.035	-	GDP-L-fucose	wild-type enzyme	637646	
2.4.1.65	0.0357	-	GDP-fucose	with Gal-beta-1,3-GlcNAc-O-(CH2)8CO2CH3, strain UA948	662137	
2.4.1.65	0.037	-	GDP-fucose	mutant W111F, with Fuc-alpha-1,2Gal-beta-1,3GlcNAc-sp-biotin	661839	
2.4.1.65	0.038	-	GDP-fucose	wildtype, with Fuc-alpha-1,2Gal-beta-1,4GlcNAc-sp-biotin	661839	
2.4.1.65	0.045	-	ancrod	enzyme form FTB	637647	
2.4.1.65	0.046	-	GDP-fucose	mutant W111A, with Fuc-alpha-1,2Gal-beta-1,3GlcNAc-sp-biotin	661839	
2.4.1.65	0.047	-	3-O-sulfoGalbeta(1,3)GlcNAcbeta-O-Al	enzyme form FTB	637647	
2.4.1.65	0.048	-	GDP-fucose	with Gal-beta-1,4beta-GlcNAc-O-(CH2)8CO2CH3, wild type, strain NCTC116639	662137	
2.4.1.65	0.0481	-	GDP-fucose	with Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3, chimeric FucT UA948(345DNPFIFC)	662137	
2.4.1.65	0.0504	-	GDP-fucose	-	661341	
2.4.1.65	0.0546	-	GDP-fucose	with Gal-beta-1,3-GlcNAc-O-(CH2)8CO2CH3, chimeric FucT 11639(347CNDAHYSALH)	662137	
2.4.1.65	0.06	-	GMP	-	637635	
2.4.1.65	0.064	-	NeuAcalpha(2,3)Galbeta(1,4)Glucal	-	637634	
2.4.1.65	0.0683	-	GDP-fucose	with Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3, strain UA948	662137	
2.4.1.65	0.07	-	NeuAcalpha(2,6)Galbeta(1,4)GlcNAc	-	637634	
2.4.1.65	0.075	-	Formic acid (2R,3R,4S,5R,6R)-2-((2R,3R,4R,5R,6R)-3-acetylamino-5-hydroxy-2-methoxy-6-methylaminomethyl-tetrahydro-pyran-4-yloxy)-4,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yl ester	pH 6.5, 37°C, recombinant FucT VI	658008	
2.4.1.65	0.1	-	3-O-sulfoGalbeta(1,3)GlcNAcbeta-O-Al	enzyme form FTA	637647	
2.4.1.65	0.1	-	Fuc-alpha-1,2Gal-beta-1,4GlcNAc-sp-biotin	mutant W124R	661839	
2.4.1.65	0.1	-	Fucalpha(1,2)Galbeta(1,3)GlcNAc	-	637645	
2.4.1.65	0.1	-	NeuAcalpha(2,3)Galbeta(1,4)GlcNAc	-	637634	
2.4.1.65	0.111	-	Siaalpha-2,3Galbeta-1,3GlcNAc-R	37°C, pH 6.5	680029	
2.4.1.65	0.114	-	Galbeta-1,3GlcNAc-R	37°C, pH 6.5	680029	
2.4.1.65	0.1145	-	GDP-D-fucose	mutant enzyme D336A	637645	
2.4.1.65	0.12	-	(Gal-3-O-Me)beta(1-3)(GlcNAc-6-O-Me)beta-O-Me	pH 6.5, 37°C, recombinant FucT VI	658008	
2.4.1.65	0.14	-	Fuc-alpha1-2Galbeta1-4GlcNAc-octyl	-	703056	
2.4.1.65	0.15	-	GlcNAcbeta(1-2)Manalpha(1-6)[GlcNAcbeta(1-2)Manalpha(1-3)]Manbeta(1-4)GlcNAcbeta(1-4)GlcNAcbeta(1-)AspNHCO-biotin	FUT10-479	704613	
2.4.1.65	0.153	-	GDP-fucose	with beta-Gal1,4-GlcNAc-O-(CH2)8CO2CH3, chimeric FucT 11639(1-359)UA948(361-462)	662137	
2.4.1.65	0.154	-	GlcNAcbeta(1-2)Manalpha(1-6)[GlcNAcbeta(1-2)Manalpha(1-3)]Manbeta(1-4)GlcNAcbeta(1-4)GlcNAcbeta(1-)AspNHCO-biotin	FUT10-391	704613	
2.4.1.65	0.16	-	2-O-MeGalbeta(1,3)GlcNAcbeta-O-Bn	enzyme form FTB	637647	
2.4.1.65	0.167	-	asialo ancrod	enzyme form FTB	637647	
2.4.1.65	0.17	-	Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3	chimeric FucT UA948(345DNPFIFC)	662137	
2.4.1.65	0.188	-	GDP-fucose	with Gal-beta-1,3-GlcNAc-O-(CH2)8CO2CH3, chimeric FucT UA948(1-360)11639(360-478)	662137	
2.4.1.65	0.2	-	Fuc-alpha-1,2Gal-beta-1,3GlcNAc-sp-biotin	wildtype	661839	
2.4.1.65	0.2	-	Fucalpha(1,2)Galbeta(1,3)GlcNAc	wild-type enzyme	637646	
2.4.1.65	0.213	-	GDP-fucose	with Gal-beta-1,3-GlcNAc-O-(CH2)8CO2CH3, chimeric FucT UA948(345DNPFIFC)	662137	
2.4.1.65	0.236	-	GDP-fucose	with Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3, chimeric FucT UA948(1-360)11639(360-478)	662137	
2.4.1.65	0.244	-	GDP-fucose	with Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3, chimeric FucT 11639(347CNDAHYSALH)	662137	
2.4.1.65	0.27	-	GalNAcbeta1-4GlcNAc-octyl	-	703056	
2.4.1.65	0.28	-	NeuAcalpha(2,3)Galbeta(1,4)GlcNAc	-	637634	
2.4.1.65	0.3	-	Fuc-alpha-1,2Gal-beta-1,3GlcNAc-sp-biotin	mutant W111F	661839	
2.4.1.65	0.3	-	Fuc-alpha-1,2Gal-beta-1,3GlcNAc-sp-biotin	mutant W111Y	661839	
2.4.1.65	0.31	-	Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3	wild type, strain NCTC116639	662137	
2.4.1.65	0.35	-	Galbeta(1-3)GlcNAcbeta-O-Me	pH 6.5, 37°C, recombinant FucT VI	658008	
2.4.1.65	0.4	-	2-O-MeGalbeta(1,3)GlcNAcbeta-O-Bn	enzyme form FTA	637647	
2.4.1.65	0.4	-	Fucalpha(1,2)Galbeta(1,3)GlcNAc	mutant enzyme D112E	637646	
2.4.1.65	0.4	-	Galbeta(1,4)GlcNAcbeta(1,2)Man	-	637634	
2.4.1.65	0.4	-	N-((1R,3R,5R,6R,7S,8R,14R,16R,17R,18S)-6,7,18-Trihydroxy-5-hydroxymethyl-16-methoxy-2,4,9,12,15-pentaoxa-tricyclo[12.3.1.03,8]octadec-17-yl)-acetamide	pH 6.5, 37°C, recombinant FucT VI	658008	
2.4.1.65	0.5	-	Fucalpha(1,2)Galbeta(1,4)GlcNAc	mutant enzyme W111R/D112E	637646	
2.4.1.65	0.5	-	Galbeta(1,4)Glc	-	637634	
2.4.1.65	0.6	-	Galbeta(1,3)GlcNAc	-	637634	
2.4.1.65	0.61	-	N-((1R,3R,5R,6R,7S,8R,14R,16R,17R,18R)-6,7,18-trihydroxy-5-hydroxymethyl-16-methoxy-11-oxo-2,4,9,15-tetraoxa-12-aza-tricyclo[12.3.1.03,8]octadec-17-yl)-acetamide	pH 6.5, 37°C, recombinant FucT VI	658008	
2.4.1.65	0.63	-	fetuin triantennary asialoglycopeptide	enzyme form FTB	637647	
2.4.1.65	0.67	-	NeuAcalpha(2,3)Galbeta(1,3)GlcNAcbeta-O-Bn	enzyme form FTB	637647	
2.4.1.65	0.7	-	Fucalpha(1,2)Galbeta(1,4)GlcNAc	mutant enzyme W111R	637646	
2.4.1.65	0.7	-	Gal-beta-1,3GlcNAcO(CH2)3NHCO(CH2)5NH-biotin	at pH 7.0 and presence of Mn2+	661313	
2.4.1.65	0.7	-	Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3	chimeric FucT 11639(1-359)UA948(361-462)	662137	
2.4.1.65	0.76	-	Galbeta(1,3)GlcNAc-(CH2)3-NHCO-(CH2)5-NH-biotin	enzyme expressed n Sf9 cells	637643	
2.4.1.65	0.77	-	NeuAcalpha(2,3)Galbeta(1,4)GlcNAcbeta(1,6)(Galbeta(1,3))GalNAcalpha-OMe	enzyme form FTB	637647	
2.4.1.65	0.8	-	Fucalpha(1,2)Galbeta(1,3)GlcNAcbeta(1,3)Galbeta(1,4)Glc	-	637634	
2.4.1.65	0.87	-	Galbeta(1,3)GlcNAc-(CH2)3-NHCO-(CH2)5-NH-biotin	enzyme expressed in Trichoplusia ni	637643	
2.4.1.65	0.9	-	Gal-beta-1,3GlcNAcO(CH2)3NHCO(CH2)5NH-biotin	at pH 4.7 and absence of Mn2+	661313	
2.4.1.65	1.1	-	Fuc-alpha-1,2Gal-beta-1,4GlcNAc-sp-biotin	wildtype	661839	
2.4.1.65	1.1	-	N-((1R,3R,5R,6R,7S,8R,13R,15R,16R,17S)-6,7,17-Trihydroxy-5-hydroxymethyl-15-methoxy-2,4,9,11,14-pentaoxa-tricyclo[11.3.1.03,8]heptadec-16-yl)-acetamide	pH 6.5, 37°C, recombinant FucT VI	658008	
2.4.1.65	1.2	-	Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3	strain UA948	662137	
2.4.1.65	1.2	-	Galbeta(1-3)GlcNAcbeta-O-Me	pH 6.5, 37°C, recombinant FucT IV	658008	
2.4.1.65	1.3	-	Formic acid (2R,3R,4S,5R,6R)-2-((2R,3R,4R,5R,6R)-3-acetylamino-5-hydroxy-2-methoxy-6-methylaminomethyl-tetrahydro-pyran-4-yloxy)-4,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yl ester	pH 6.5, 37°C, recombinant FucT IV	658008	
2.4.1.65	1.3	-	Fuc-alpha-1,2Gal-beta-1,4GlcNAc-sp-biotin	mutant W124Y	661839	
2.4.1.65	1.3	-	Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3	chimeric FucT UA948(1-360)11639(360-478)	662137	
2.4.1.65	1.43	-	fetuin triantennary glycopeptide	enzyme form FTB	637647	
2.4.1.65	1.5	-	Gal-beta-1,3GlcNAcO(CH2)3NHCO(CH2)5NH-biotin	at pH 4.7 and presence of Mn2+	661313	
2.4.1.65	1.52	-	Fucalpha(1,2)Galbeta(1,4)Glc	enzyme form FTB	637647	
2.4.1.65	1.6	-	Galbeta(1,4)GlcNAc	-	637635	
2.4.1.65	1.9	-	Galbeta(1,3)GlcNAc	-	637635	
2.4.1.65	2	-	Fucalpha(1,2)Galbeta(1,3)GlcNAc	mutant enzyme W111R/D112E	637646	
2.4.1.65	2.2	-	Gal-beta-1,4-GlcNAc-O-(CH2)8CO2CH3	chimeric FucT 11639(347CNDAHYSALH)	662137	
2.4.1.65	2.4	-	Galbeta(1,3)GlcNAcbeta(1,3)Galbeta(1,4)Glc	-	637635	
2.4.1.65	2.5	-	Fuc-alpha-1,2Gal-beta-1,3GlcNAc-sp-biotin	mutant W111A	661839	
2.4.1.65	2.5	-	NeuAcalpha(2,3)Galbeta(1,3)GlcNAcbeta-O-Bn	enzyme form FTA	637647	
2.4.1.65	2.7	-	(Gal-3-O-Me)beta(1-3)(GlcNAc-6-O-Me)beta-O-Me	pH 6.5, 37°C, recombinant FucT IV	658008	
2.4.1.65	3	-	N-((1R,3R,5R,6R,7S,8R,13R,15R,16R,17S)-6,7,17-trihydroxy-5-hydroxymethyl-15-methoxy-2,4,9,11,14-pentaoxa-tricyclo[11.3.1.0 3,8]heptadec-16-yl)-acetamide	pH 6.5, 37°C, recombinant FucT VI	658008	
2.4.1.65	3.3	-	Gal-beta-1,3GlcNAcO(CH2)3NHCO(CH2)5NH-biotin	at pH 7.0 and absence of Mn2+	661313	
2.4.1.65	3.3	-	NeuAcalpha(2,3)Galbeta(1,4)GlcNAcbeta(1,6)(Galbeta(1,3))GalNAcalpha-OMe	enzyme form FTB	637647	
2.4.1.65	3.6	-	Galbeta1-4GlcNAc-4-nitrophenyl	-	703056	
2.4.1.65	3.8	-	Fucalpha(1,2)Galbeta(1,3)GlcNAc	fucosyltransferase III mutant enzyme D336A	637645	
2.4.1.65	3.8	-	Galbeta(1,4)GlcNAcbeta(1,3)Galbeta(1,4)Glc	-	637635	
2.4.1.65	3.8	-	GalNAcbeta1-4GlcNAc-diaminopimelyl	-	703056	
2.4.1.65	5	-	N-((1R,3R,5R,6R,7S,8R,14R,16R,17R,18S)-6,7,18-Trihydroxy-5-hydroxymethyl-16-methoxy-2,4,9,12,15-pentaoxa-tricyclo[12.3.1.03,8]octadec-17-yl)-acetamide	pH 6.5, 37°C, recombinant FucT IV	658008	
2.4.1.65	5.7	-	Galbeta1,3GlcNAc-O(CH2)8CO2CH3	truncated enzyme UA948(1-428)	680736	
2.4.1.65	8.1	-	Galbeta(1,4)GlcNAc	-	637640	
2.4.1.65	8.4	-	Gal-beta-1,3-GlcNAc-O-(CH2)8CO2CH3	strain UA948	662137	
2.4.1.65	9.7	-	Gal-beta-1,3-GlcNAc-O-(CH2)8CO2CH3	chimeric FucT UA948(1-360)11639(360-478)	662137	
2.4.1.65	11	-	2'-fucosyllactose	-	637635	
2.4.1.65	11	-	N-((1R,3R,5R,6R,7S,8R,13R,15R,16R,17S)-6,7,17-Trihydroxy-5-hydroxymethyl-15-methoxy-2,4,9,11,14-pentaoxa-tricyclo[11.3.1.03,8]heptadec-16-yl)-acetamide	pH 6.5, 37°C, recombinant FucT IV	658008	
2.4.1.65	12	-	Galbeta(1,6)Galbeta(1,4)Glc	-	637635	
2.4.1.65	12.7	-	Galbeta(1,3)GlcNAc	-	637640	
2.4.1.65	13.3	-	Galbeta1,3GlcNAc-O(CH2)8CO2CH3	full-length enzyme	680736	
2.4.1.65	16	-	N-((1R,3R,5R,6R,7S,8R,14R,16R,17R,18R)-6,7,18-trihydroxy-5-hydroxymethyl-16-methoxy-11-oxo-2,4,9,15-tetraoxa-12-aza-tricyclo[12.3.1.03,8]octadec-17-yl)-acetamide	pH 6.5, 37°C, recombinant FucT IV	658008	
2.4.1.65	20.8	-	Gal-beta-1,3-GlcNAc-O-(CH2)8CO2CH3	chimeric FucT 11639(347CNDAHYSALH)	662137	
2.4.1.65	22.7	-	Gal-beta-1,3-GlcNAc-O-(CH2)8CO2CH3	chimeric FucT UA948(345DNPFIFC)	662137	
2.4.1.65	25	-	N-((1R,3R,5R,6R,7S,8R,13R,15R,16R,17S)-6,7,17-trihydroxy-5-hydroxymethyl-15-methoxy-2,4,9,11,14-pentaoxa-tricyclo[11.3.1.0 3,8]heptadec-16-yl)-acetamide	pH 6.5, 37°C, recombinant FucT IV	658008